VBLT - Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q4 2019 Results - Earnings Call Transcript
Vascular Biogenics Ltd. (VBLT)
Q4 2019 Results Earnings Conference Call
March 19, 2020 08:30 AM ET
Company Participants
Michael Wood - IR, LifeSci Advisors
Dror Harats - CEO
Amos Ron - CFO
Conference Call Participants
Kevin DeGeeter - Oppenheimer
Sam Slutsky - LifSci Capital
Ram Swayampakula - H.C. Wainwright
Soumit Roy - Jones Trading
Jonathan Kreizman - Valore Research
Presentation
Operator
Greetings and welcome to the VBL Therapeutics Fourth Quarter and Full Year 2019 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation.